|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0012634,
umls-concept:C0017168,
umls-concept:C0030705,
umls-concept:C0032659,
umls-concept:C0034656,
umls-concept:C0081876,
umls-concept:C0085154,
umls-concept:C0205430,
umls-concept:C0232483,
umls-concept:C0267055,
umls-concept:C0564405,
umls-concept:C0723011,
umls-concept:C1457887,
umls-concept:C1707455,
umls-concept:C2587213
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2001-11-5
|
|
pubmed:abstractText |
Gastroesophageal reflux disease (GERD) in primary care practice presents symptomatically, and resources to distinguish promptly between erosive esophagitis and endoscopy-negative reflux disease (ENRD) are limited. It is therefore important to determine the roles of proton pump inhibitors and histamine-2-receptor antagonists for first-line symptom-based therapy in patients with erosive esophagitis and ENRD. The aim of this study was to compare pantoprazole 40 mg once daily versus nizatidine 150 mg b.i.d. in a mixed GERD patient population with ENRD or erosive esophagitis (Savary-Miller grades 1-3).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0002-9270
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
96
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2849-57
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11695354-2-Pyridinylmethylsulfinylbenzimidazoles,
pubmed-meshheading:11695354-Adult,
pubmed-meshheading:11695354-Anti-Ulcer Agents,
pubmed-meshheading:11695354-Benzimidazoles,
pubmed-meshheading:11695354-Double-Blind Method,
pubmed-meshheading:11695354-Enzyme Inhibitors,
pubmed-meshheading:11695354-Esophagitis, Peptic,
pubmed-meshheading:11695354-Esophagoscopy,
pubmed-meshheading:11695354-Female,
pubmed-meshheading:11695354-Gastroesophageal Reflux,
pubmed-meshheading:11695354-H(+)-K(+)-Exchanging ATPase,
pubmed-meshheading:11695354-Histamine H2 Antagonists,
pubmed-meshheading:11695354-Humans,
pubmed-meshheading:11695354-Male,
pubmed-meshheading:11695354-Middle Aged,
pubmed-meshheading:11695354-Nizatidine,
pubmed-meshheading:11695354-Omeprazole,
pubmed-meshheading:11695354-Sulfoxides
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
|
|
pubmed:affiliation |
Division of Gastroenterology, McMaster University, Hamilton, Ontario, Canada.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
